Now Available:
Download the podcast of Dr. Cohen's video presentation

With biweekly and special edition newsletters, Musculoskeletal Report is the top online resource for staying abreast of the most current and clinically relevant information in the field of musculoskeletal disease and treatment.

MSK Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts. With an editorial board of internationally recognized thought leaders, MSK Report is positioned to provide unparalleled quality news reporting with the highest level of credibility.

Consumer News: Learn what your patients are reading in the popular press

MGH Center is a Pioneer in Knee Repair
Physicians at the Massachusetts General Hospital sports medicine center are experimenting with new techniques for joint reconstruction in athletes...

New from PubMed: Keep up-to-date with what is on PubMed

Inverse Relationship Between Vertebral Fractures and Spine Osteoarthritis in Postmenopausal Women With Osteoporosis
Disc space narrowing decreases the incidence of vertebral fracture in postmenopausal women with osteoporosis...



MSK Video Report:
Current and Available Treatment Options
Dr. Marc Cohen looks at the current state of infusion therapy for the treatment of RA...

Arthritis: Cochrane Reviewers Find Little Evidence That Antidepressants Help Chronic Low Back Pain
A Cochrane Review found little evidence to support the common practice of prescribing antidepressants for patients with nonspecific chronic low back pain...

Arthritis: IL-27 Shows Promise for Treating Inflammatory Arthritis
Interleukin-27 (IL-27) can attenuate collagen-induced arthritis when given early in the disease course by blocking Th17 differentiation...

Bones: Cochrane Review: Alendronate Safe, Effective for Secondary Fracture Prevention
Alendronate can stave off vertebral, nonvertebral, hip, and wrist fractures among postmenopausal women with low bone density and/or those with previous fractures...

BioPharm Business: Centocor Announces Ustekinumab (CNTO 1275) Biologics License Application Accepted by US FDA for the Treatment of Psoriasis
Centocor, Inc announced that the Biologics License Application for ustekinumab (CNTO 1275), a fully-human monoclonal antibody targeting the cytokines interleukin (IL)-12 and IL-23, has been accepted for review by the US FDA for the treatment of chronic moderate-to-severe plaque psoriasis in adults...

BioPharm Business: Amgen, Wyeth Report Enbrel (etanercept) Significantly Reduced Levels of CRP, a Marker of Inflammation, in Patients with Moderate-to-Severe Plaque Psoriasis
Amgen Inc and Wyeth Pharmaceuticals announced findings from a retrospective analysis demonstrating that Enbrel (etanercept), a fully human soluble TNF receptor, reduced C-reactive protein (CRP) in patients with moderate-to-severe plaque psoriasis...

BioPharm Business: SantoSolve Reports Topical Analgesic Phase II Study Met Primary Endpoint in Patients With Knee OA
SantoSolve AS announced positive results for 2PX, its topical analgesic formulated for subdermal pain treatment in patients with osteoarthritis of the knee...

To remove your e-mail address from our mailing list, please reply to this e-mail with "unsubscribe" in the subject line. For questions and comments regarding this newsletter please contact .